Unfamiliar; not sympathomimetic; may possibly raise dopamine amounts from the Mind by binding for the dopamine transporter and inhibiting dopamine reuptakeBelzutifan is often a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may possibly maximize incidence or severity of adverse outcomes. Keep track of for anemia and hypoxia and decreas